RMD - ResMed Non-GAAP EPS of $2.13 beats by $0.22 revenue of $1.2B beats by $30M April, 25 2024 04:30 PM ResMed Inc. 2024-04-25 16:30:00 ET More on ResMed ResMed: Not A Sleeper ResMed Q3 2024 Earnings Preview Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down Seeking Alpha’s Quant Rating on ResMed Historical earnings data for ResMed For further details see: ResMed Non-GAAP EPS of $2.13 beats by $0.22, revenue of $1.2B beats by $30M